Tissue viral DNA is associated with chronic allograft nephropathy

Pediatric Transplantation

Volumn 9, Issue 5, 2005, Pages 598-603

  Šebeková, Katarína ^a   Feber, Janusz ^b   Carpenter, Blair ^b   Shaw, Laura ^b   Karnauchow, Tim ^b   Diaz Mitoma, Francisco ^b   Filler, Guido ^b  

^a SLOVAK MEDICAL UNIVERSITY   (Slovakia)

^b CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

Banff; Chronic allograft nephropathy; Cystatin C; Cytomegalovirus; Epstein barr virus; Human herpesvirus; Human herpesvirus 6; Human herpesvirus 7

Indexed keywords

ACICLOVIR; AZATHIOPRINE; CYCLOSPORIN; CYSTATIN C; GANCICLOVIR; INTERLEUKIN 2 RECEPTOR ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; VALGANCICLOVIR; VIRUS DNA;

ADOLESCENT; ARTICLE; CHILD; CHRONIC ALLOGRAFT NEPHROPATHY; CLINICAL ARTICLE; CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN HERPESVIRUS 6; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; KIDNEY TUBULE DISORDER; LIVER TRANSPLANTATION; MALE; POLYMERASE CHAIN REACTION; PROPHYLAXIS; VIRUS INFECTION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; CYTOMEGALOVIRUS; DNA, VIRAL; FEMALE; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; HERPESVIRUS 4, HUMAN; HERPESVIRUS 6, HUMAN; HERPESVIRUS 7, HUMAN; HUMANS; INFANT; KIDNEY; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; POLYMERASE CHAIN REACTION;

EID: 26244450808     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2005.00347.x     Document Type: Article

References (23)

1. LOPEZ C, SIMMONS RL, MAUER SM, NAJARIAN JS, GOOD RA, GENTRY S. Association of renal allograft rejection with virus infections. Am J Med 1974: 56: 280-289.
2. BOCK GH, SULLIVAN EK, MILLER D, et al. Cytomegalovirus infections following renal transplantation - effects on antiviral prophylaxis: A report of the North American pediatric renal transplant cooperative study. Pediatr Nephrol 1997: 11: 665-671.
3. GRIFFITHS PD, CLARK DA, EMERY VC. Betaherpesviruses in transplant recipients. J Antimicrob Chemother 2000: 45(Suppl. T3): 29-34.
4. RAZONABLE RR, RIVERO A, RODRIGUEZ A, et al. Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir. J Infect Dis 2001: 184: 1461-1464.
5. WADE AW, MCDONALD AT, ACOTT PD, LEE S, CROCKER JF. Human herpes virus-6 or Epstein-Barr virus infection and acute allograft rejection in pediatric kidney transplant recipients: Greater risk for immunologically naive recipients. Transplant Proc 1998: 30: 2091-2093.
6. ADAM E, MELNICK JL, PROBTSFIELD JL, et al. High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet 1987: 2: 291-293.
7. LOEBE M, SCHULER S, ZAIS O, WARNECKE H, FLECK E, HETZER R. Role of cytomegalovirus infection in the development of coronary artery disease in the transplanted heart. J Heart Transplant 1990: 9: 707-711.
8. EVERETT JP, HERSHBERGER RE, NORMAN DJ, et al. Prolonged cytomegalovirus infection with viremia is associated with development of cardiac allograft vasculopathy. J Heart Lung Transplant 1992: 11: S133-S137.
9. GJERTSON DW. Look-up survival tables for living-donor renal transplants: OPTN/UNOS data 1995-2002. In: CECKA JM, TERASAKI PI, eds. Clinical Transplants 2003: 337-386.
10. WOMER KL, VELLA JP, SAYEGH MH. Chronic allograft dysfunction: mechanisms and new approaches to therapy. Semin Nephrol 2000: 20: 126-147.
11. GUPTA M, FILLER G, KOVESI T, et al. Quantitative tissue polymerase chain reaction for Epstein-Barr virus in pediatric solid organ recipients. Am J Kidney Dis 2003: 41: 212-219.
12. GUPTA M, DIAZ-MITOMA F, FEBER J, SHAW L, FORGET C, FILLER G. Tissue HHV6 and 7 determination in pediatric solid organ recipients - a pilot study. Pediatr Transplant 2003: 7: 458-463.
13. JOHNSON G, NELSON S, PETRIC M, TELLIER R. Comprehensive PCR-based assay for detection and species identification of human herpesviruses. J Clin Microbiol 2000: 38: 3274-3279.
14. GERSTENKORN C, ROBERTSON H, MOHAMED MA, O'DONNELL M, ALI S, TALBOT D. Detection of cytomegalovirus (CMV) antigens in kidney biopsies and transplant nephrectomies as a marker for renal graft dysfunction. Clin Chem Lab Med 2000: 38: 1201-1203.
15. CAINELLI F, VENTO S. Infections and solid organ transplant rejection: a cause-and-effect relationship? Lancet Infect Dis 2002: 2: 539-549.
16. TONG CY, BAKRAN A, PEIRIS JS, MUIR P, HERRINGTON CS. The association of viral infection and chronic allograft nephropathy with graft dysfunction after renal transplantation. Transplantation 2002: 74: 576-578.
17. LIAPIS H, STORCH GA, HILL DA, RUEDA J, BRENNAN DC. CMV infection of the renal allograft is much more common than the pathology indicates: A retrospective analysis of qualitative and quantitative buffy coat CMV-PCR, renal biopsy pathology and tissue CMV-PCR. Nephrol Dial Transplant 2003: 18: 397-402.
18. RACUSEN LC, SOLEZ K, COLVIN RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999: 55: 713-723.
19. FILLER G, LEPAGE N. Should the Schwartz formula for estimation of GFR be replaced by cystatin C formula? Pediatr Nephrol 2003: 18: 981-985.
20. PAYA C, HUMAR A, DOMINGUEZ E, et al. Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 2004: 4: 611-620.
21. SHROFF R, TROMPETER R, CUBITT D, THAKER U, REES L. Epstein-Barr virus monitoring in paediatric renal transplant recipients. Pediatr Nephrol 2002: 17: 770-775.
22. HEEMANN UW, AZUMA H, TULLIUS SG, SCHMID C, PHILIPP T, TILNEY NL. Infections and reduced functioning kidney mass induce chronic rejection in rat kidney allografts. Clin Nephrol 1996: 46: 34-38.
23. ZAMORA MR, NICOLLS MR, HODGES TN, et al. Following universal prophylaxis with intravenous ganciclovir and cytomegalovirus immune globulin, valganciclovir is safe and effective for prevention of CMV infection following lung transplantation. Am J Transplant 2004: 4: 1635-1642.